Details of the Drug Reposition

General Information of This Drug (ID: DMQXO1I)

Drug Name
Salicylamide   DMQXO1I
Synonyms
Sodium salicylamide; SALICYLAMIDE SODIUM; UNII-OZV98V4536; 2-Hydroxybenzamide monosodium salt; Salicylamide, monosodium salt; OZV98V4536; sodium 2-carbamoylphenolate; Benzamide, 2-hydroxy-, monosodium salt; 2-(Sodiooxy)benzamide; 87-17-2 (Parent); 65-45-2 (Parent); Sodium 2-(anilinocarbonyl)phenolate; EINECS 219-990-2; 36205-82-0; LS-144175; Benzamide, 2-hydroxy-, monosodium salt (9CI); Benzamide, 2-hydroxy-N-phenyl-, monosodium salt
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Headache DISK4TGU 8A80-8A84 Approved [1]
Back pain DISDSMNI ME84.Z Approved [2]
Fever DISJGEAQ MG26 Approved [3]
Pain DIS4RWOW MG30-MG3Z Approved [4]
------------------------------------------------------------------------------------

References

1 Evaluation of acetaminophen-salicylamide combinations in treatment of headache. J Clin Pharmacol J New Drugs. 1967 May-Jun;7(3):150-5.
2 Augmentation of musculoskeletal soft tissue morphology within low back pain patients may suggest the presence of physiological stress shielding: An in vivo study. J Biomech. 2024 Jan;162:111894.
3 The influence of pyrogen-induced fever on salicylamide metabolism in man. J Clin Invest. 1972 Nov;51(11):2959-66.
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015